Neurotech International (ASX:NTI) Share Price and News - StockTrack

Market Cap (19-Sep) $15,812,900 (1,318th)	Close (30-Jun) $0.040 0 (0%)	Volume (30-Jun) 2,106,389	Shortsold (23-Jan) 143,231 (0.01%) (538th)
52w High $0.029	52w Low $0.010	P/E -	EPS 0

	Subject
	NTI NTI Ann: Neurotech CEO to Present at Bioshares Conference
	1 (current) 2 3
	NTI NTI Ann: Key Development in Current Paediatric ASD Study
	NTI NTI Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NTI NTI Ann: Q&A With Company CEO, Dr Alex Andrews
	NTI NTI Ann: Successful Landmark Study in Paediatric ASD
	NTI NTI Ann: Notification regarding unquoted securities - NTI
	NTI NTI Ann: Medicinal Cannabis Presentation
	NTI NTI Ann: Proposed issue of securities - NTI
	NTI NTI Ann: Appointment of Chief Executive Officer
	NTI NTI Ann: Appendix 4D and Half Year Accounts
	NTI NTI Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NTI NTI Ann: Application for quotation of securities - NTI
	NTI NTI Ann: Change of Registry Address
	NTI NTI Ann: Change of Director's Interest Notice x 2
	NTI NTI Ann: Notification regarding unquoted securities - NTI
	NTI NTI Ann: Notification regarding unquoted securities - NTI
	NTI NTI Ann: Preclinical Success with Targeted Combination Therapies
	NTI NTI Ann: Results of Meeting
	NTI NTI Ann: Application for quotation of securities - NTI
	NTI NTI Ann: Change of Director's Interest Notice
	NTI NTI Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NTI NTI Ann: Investor Presentation
	NTI NTI Ann: NTI to Present at the South-West Connect ASX Showcase
	NTI NTI Ann: Successful Completion of Preclinical MS Studies
	NTI NTI Ann: Annual Report (Typeset)
	NTI NTI Ann: Notice of Annual General Meeting/Proxy Form
	NTI NTI Ann: Response to ASX Query Letter
	NTI NTI Ann: Provisional Patent Lodgements
	NTI NTI Ann: Trading Halt
	NTI NTI Ann: ASX Listing Rule 3.13.1 Notice Regarding AGM
	NTI NTI Ann: NTI164 Clinical Program Update
	NTI NTI Ann: IRD Invest Conference - Webinar Presentation
	NTI NTI Ann: Ceasing to be a substantial holder
	NTI NTI Ann: Appendix 4G and Corporate Governance Statement
	NTI NTI Ann: Appendix 4E and Annual Report
	NTI NTI Ann: Investor Webinar Presentation
	NTI NTI Ann: Investor Presentation
	NTI NTI Ann: Quarterly Report and Appendix 4C
	NTI NTI Ann: Phase I/II Clinical Trial Update
	NTI NTI Ann: Change of Director's Interest Notice
	NTI NTI Ann: Change of Director's Interest Notice
	NTI NTI Ann: Further Success with Preclinical Testing Program - MS Models
	NTI NTI Ann: Appendix 3G
	NTI NTI Ann: Update - Proposed issue of securities - NTI
	NTI NTI Ann: NTI to Present at the Gold Coast Investment Showcase
	NTI NTI Ann: Change of Director's Interest Notice
	NTI NTI Ann: Investor Presentation
	NTI NTI Ann: NTI Strains Demonstrate Potential Benefits for MS Management
	NTI NTI Ann: Proposed issue of Securities - NTI
	NTI NTI Ann: Initial Director's Interest Notice

Similar Companies

Atomo Diagnostics

AT1

Cochlear

COH

CleanSpace Holdings

CSX

Cyclopharm

CYC

EMvision Medical Devices

EMV

Imagion Biosystems

IBX

ImpediMed

IPD

Micro-X

MX1

Respiri

RSH

SomnoMed

SOM

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.02	0	0.00 (15.79%)
12-Sep	$0.02	1,832,233	0.00 (0.00%)
11-Sep	$0.02	498,880	+0.01 (35.71%)
05-Sep	$0.01	3,085,995	+0.00 (7.69%)
04-Sep	$0.01	2,126,899	0.00 (7.14%)
03-Sep	$0.01	1,129,373	0.00 (0.00%)
29-Aug	$0.01	307,279	+0.00 (7.69%)
28-Aug	$0.01	479,212	0.00 (7.14%)
22-Aug	$0.01	401,044	0.00 (3.45%)
21-Aug	$0.01	170,000	+0.00 (3.57%)
15-Aug	$0.01	1,017,925	0.00 (0.00%)
14-Aug	$0.01	233,553	0.00 (12.50%)
07-Aug	$0.02	343,790	0.00 (20.00%)
31-Jul	$0.02	1,483,015	0.00 (9.09%)
30-Jul	$0.02	186,231	+0.00 (4.76%)
5 up, 7 down, and 3 flat days

High $0.04	Low $0.04	Trades 37	Turnover $81,892	Volume 2,106,389
30 June 2023 at 3:45pm

High $0.04	Low $0.04	Trades 37	Turnover $81,892	Volume 2,106,389
30 June 2023 at 3:45pm

Neurotech International Health Care

$0.040 0.004 (11.11%)

$0.040 0.004 (11.11%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices